Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06986447) titled 'MASH/MetALD Consortium for the Assessment of Non-Invasive Testing in Monitoring Interventions, Treatment Response, and Major Liver-Related Outcomes' on May 15.

Study Type: Observational

Primary Sponsor: HRI-MAIL-NIT

Condition: Metabolic Dysfunction-Associated Steatotic Liver Disease MASLD MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis) MetALD

Recruitment Status: Not recruiting

Date of First Enrollment: June 2025

Target Sample Size: 1689

To know more, visit https://clinicalt...